Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)

NCT02275780 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

769

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1

Interventions

DRUG: Doravirine
DRUG: Darunavir
DRUG: Ritonavir
DRUG: TRUVADA™ or EPZICOM™/KIVEXA™

Sponsor

Merck Sharp & Dohme LLC